On the Finnish Independence Day, the President of the Republic of Finland and Grand Master of the of the Orders of the White Rose of Finland and the Lion of…
Turku Bioscience research groups receiving significant funding for 2020–2023 from the Flagship Programme of the Academy of Finland
The research and development initiative ‘Innovation Ecosystem Based on the Immune System (InFLAMES)’ has received €5.6M funding for 2020–2023 from the Flagship Programme of the Academy of Finland. The InFLAMES…
Atomic Force Microscopy: Describing the mechanical properties of diverse materials
In this interview, Camilo Guzmán, Manager of Euro-BioImaging’s Finnish Advanced Light Microscopy Node, explains how to use Atomic…
Researchers Develop a Simplified Method to Modify Disease Signaling with Light
Cellular optogenetics is a technique that allows researchers to use light to precisely control cell signaling and function in space and time enabling the investigation of mechanisms involved in disease…
Turku Bioscience research groups successful in receiving funding from The Health from Science (TERVA) Academy Programme follow-up call
The Health from Science (TERVA) Academy Programme seeks bold, new research initiatives that can solve health issues related to major public health diseases. The programme highlights the importance of scientific…
New agreement signed with i2020 to tackle neurological diseases
We are delighted to announce that that we have another agreement signed with i2020 accelerator, following on from the one in 2019. This supports our group’s…
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test
A recent study from Finland reports that a protein kinase called LRRK2 is hyperactive in skin samples from Parkinson’s disease patients which leads to a decrease in protein synthesis.
University of Turku Signed a Significant Drug Development Licensing Agreement
The University of Turku has entered into a licensing agreement with an international pharma company related to targeting of CIP2A oncoprotein. …
Jane and Aatos Erkko Foundation Grants €1 million for Westermarck group
Jane and Aatos Erkko Foundation has awarded 975 000 € for research led by professor Jukka Westermarck and focused on phosphorylation mechanism under RAS oncoprotein.
New insights into regulation of human T-cells
Dissertation: Kartiek Kanduri, M.Sc. 5.6.2020, medical microbiology and immunology Kartiek Kanduri discovered several novel factors that regulate T-cell differentiation and function, Understanding the regulation of immune response is central for…